PLSE
HEALTHCAREPulse Biosciences Inc
AI Insight
What's Moving PLSE Today?
No stock-specific AI insight has been generated for PLSE yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$12.56$28.53
$25.95
Fundamentals
Market Cap$1.8B
P/E Ratio—
EPS$-1.10
Dividend Yield—
Dividend / Share—
ROE-80.7%
Profit Margin—
Debt / Equity—
Trading
Volume180K
Avg Volume (10D)—
Shares Outstanding69.2M
PLSE News
23 articles- Pulse Biosciences, Inc. Announces Planned Redemption of WarrantsYahoo Finance·Jun 10, 2026
- Did New Analyst Coverage and Insider Buying Just Shift Pulse Biosciences' (PLSE) Investment Narrative?Yahoo Finance·Jun 9, 2026
- PLSE Initiates Coverage On by Canaccord Genuity -- Price Target Set at $32GuruFocus·Jun 4, 2026
- Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026Yahoo Finance·May 27, 2026
- Here's Why Pulse Biosciences, Inc (PLSE) is a Great Momentum Stock to BuyYahoo Finance·May 26, 2026
- Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors.Motley Fool·May 17, 2026
- Pulse Biosciences names new CEO, reassigns former leaderMedTech Dive·May 17, 2026
- ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 MillionYahoo Finance·May 12, 2026
- Is Pulse Biosciences (PLSE) Quietly Redefining Its Core Identity Around Atrial Fibrillation?Yahoo Finance·May 10, 2026
- Pulse Biosciences Q1 Earnings Call HighlightsMarketbeat·May 8, 2026
- PLSE Q1 2026 Earnings TranscriptMotley Fool·May 8, 2026
- Pulse Biosciences to Present at the BofA Securities 2026 Healthcare ConferenceYahoo Finance·May 8, 2026
- Pulse Biosciences (PLSE) Upgraded to Buy: What Does It Mean for the Stock?Yahoo Finance·May 7, 2026
- Turbett Surgical Appoints Kevin Danahy as President and Chief Executive Officer to Lead Growth PhaseYahoo Finance·May 6, 2026
- Pulse Biosciences (PLSE) Q1 2025 Earnings TranscriptThe Motley Fool·May 4, 2026
- PLSE Q4 2025 Earnings TranscriptMotley Fool·May 4, 2026
- Pulse Biosciences, Inc (PLSE) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·May 4, 2026
- Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial ResultsYahoo Finance·May 4, 2026
- Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026Yahoo Finance·Apr 25, 2026
- Pulse Biosciences Trials And Conference Spotlight Reframe Pulse Field Ablation StoryYahoo Finance·Apr 23, 2026
- Pulse Biosciences (PLSE) Enrolls Its First Patients in a Pivotal Atrial Fibrillation TrialYahoo Finance·Apr 20, 2026
- Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual MeetingYahoo Finance·Apr 20, 2026
- Pulse Biosciences to Host Analyst Event on April 25, 2026Yahoo Finance·Apr 17, 2026
All 23 articles loaded
Price Data
Open$25.28
Previous Close$25.95
Day High$26.58
Day Low$25.21
52 Week High$28.53
52 Week Low$12.56
52-Week Range
$12.56$28.53
$25.95
Fundamentals
Market Cap$1.8B
P/E Ratio—
EPS$-1.10
Dividend Yield—
Dividend / Share—
ROE-80.7%
Profit Margin—
Debt / Equity—
Trading
Volume180K
Avg Volume (10D)—
Shares Outstanding69.2M
About Pulse Biosciences Inc
Pulse Biosciences, Inc. is a bioelectrical medicine startup. The company is headquartered in Hayward, California.
HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL INSTRUMENTS & SUPPLIES
CIK—
Composite FIGI—
Share Class FIGI—